Martlet Capital

Martlet Capital is a pre-seed and seed stage investor providing patient capital to deep technology and life science startups with high growth potential. They seek to support entrepreneurs with value beyond capital, leveraging their experience in helping companies scale from first-round through to exit. Martlet Capital invests in ambitious entrepreneurs advancing science and technology to deliver innovation across a range of sectors including artificial intelligence, digital health and personalised medicine, genomics, human machine interfaces, new materials and nanotechnology, next generation communications, quantum technologies and photonics, robotics, semiconductors, sensing, space technology, sustainable technologies, synthetic biology and techbio. Martlet focuses on B2B startups operating in the deep tech and life sciences sectors. Their strategy involves early-stage investments that allow them to work closely with portfolio companies as they scale. Martlet's operational VC business is owned and portfolio managed by EMV Capital, integrating Martlet’s Cambridge roots with EMV's wider EIS strategy. The firm aims to replace polluting plastics, as seen with Xampla, and support the development of quantum computing networks through investments in companies like Nu Quantum. Martlet Capital also is committed to helping make the Metaverse more appealing and lifelike through its investments in companies like AllFocal Optics.